Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2018

May 15, 2018

SELL
$13.76 - $17.12 $14.4 Million - $18 Million
-1,049,700 Reduced 79.06%
278,100 $4.18 Million
Q4 2017

Feb 14, 2018

BUY
$12.51 - $16.24 $4.41 Million - $5.73 Million
352,800 Added 36.18%
1,327,800 $19.1 Million
Q3 2017

Nov 14, 2017

BUY
$11.74 - $15.78 $11.4 Million - $15.4 Million
975,000
975,000 $14.7 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.7B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.